NF Type 1 and Cancer Risk and Screening

An article by Sharon Reynolds from the National Cancer Institute highlights the importance of people with neurofibromatosis type 1 (NF1) to be diligent about paying attention to their bodies and symptoms to help detect cancer. NF1 is known to cause neurofibromas which are normally benign, however people with NF1 may be at a greater risk of developing certain cancers. One of those cancers being breast cancer. New guidelines suggest that those with NF1 should be screened for breast cancer as early as age 30 compared to the average recommended screening age of 40. Prevention and early detection are key to survival rates so just as the article advises, if you feel something do something, and talk with your doctor about your concerns. Sharon Reynolds article would be good resource to share with your doctor to start the conversation. For more information and to read this article in its entirety please visit the following link.

Recent Posts

  • Why Clinical Trials Matter, and Why They Matter Especially for NF

    Every treatment that exists today: every medication, every therapy, every breakthrough, started somewhere. It started with a question, a hypothesis, and eventually, a clinical trial. May 20 is National Clinical Trials Day, a moment to recognize the remarkable system that turns scientific ideas into real-world answers. For the NF community (patients, families, caregivers, and advocates)... Read More
  • Skylar's Story: Strength, Courage & a New Beginning 

    Some journeys begin before a child can even walk. For Skylar, hers started at just 5 months old, when she broke her left leg. It would be the first of many chapters in a story defined not by hardship, but by an extraordinary spirit that refused to be held back.  A week after that initial... Read More

Responses

Respond

Your email address will not be published. Required fields are marked *